This article was published in Science Business 16 January 2020 by Florin Zubașcu.
Alarm over the rise of antimicrobial resistance has prompted an increase in early stage research and led to the discovery of a number of new antibiotics, but for the pharmaceutical industry public investment overall remains at “concerning levels”, and more money needs to be invested in late stage R&D.